C0341950||Severe Preeclampsia
C0026896||Myasthenia Gravis
C0026896||Myasthenia gravis
C0026896||Myasthenia gravis
C0004364||autoimmune disease
C0151786||muscle weakness
C0035150||reproductive
C0026896||myasthenic
C0009566||complications
C0032961||pregnancy
C0032914||Preeclampsia
C0024480||magnesium sulfate
C0036572||seizure
C0199176||prophylaxis
C0024480||magnesium sulfate
C1444657||contraindicated
C0026896||Myasthenia gravis
C0027740||nerve
C0026845||muscle
C0086699||connections
C1708063||first-line
C0585941||antihypertensive medications
C0026896||Myasthenia gravis
C4086268||exacerbation
C0026896||Myasthenia gravis
C0341950||severe preeclampsia
C0377265||levetiracetam
C0585941||antihypertensive medications
C0348016||intravenous
C0022860||labetalol
C0026896||Myasthenia gravis
C0032914||preeclampsia
C0420616||examined
C0565867||delivery methods
C0003286||anticonvulsants
C0585941||antihypertensive medications